Walvax Biotechnology Co.,Ltd.’s Net Profit Dropped 13.7% in First Quarter of 2022

Walvax Biotechnology Co.,Ltd. (云南沃森生物技术股份有限公司) (300142.SZ) reported a net profit of 66.7 million yuan in the first quarter of 2022, down 13.7% year-on-year.

Meanwhile, the company posted 655.9 million yuan in revenue, up 51.3% year-on-year.

At the end of the reporting period, it had 14 billion yuan in total assets and 3.7 billion yuan in total liabilities, with a liability-to-asset ratio of 26.1%.